학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 112건 | 목록 1~10
Academic Journal
Geurts BS; Netherlands Cancer Institute, Netherlands.; Zeverijn LJ; Netherlands Cancer Institute, Amsterdam, Netherlands.; Leek LVM; Netherlands Cancer Institute, Amsterdam, Netherlands.; van Berge Henegouwen JM; Erasmus MC, Rotterdam, Netherlands.; Hoes LR; Netherlands Cancer Institute, Amsterdam, Netherlands.; van der Wijngaart H; Maastricht University Medical Centre, Netherlands.; van der Noort V; Netherlands Cancer Institute, Amsterdam, Netherlands.; van de Haar J; The Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands.; van Ommen-Nijhof A; The Netherlands Cancer Institute, Netherlands.; Kok M; Netherlands Cancer Institute, Amsterdam, Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, Netherlands.; Jansen AML; University Medical Center Utrecht, Utrecht, Utrecht, Netherlands.; de Leng WWJ; University Medical Center Utrecht, Utrecht, Utrecht, Netherlands.; de Jonge MJA; Erasmus MC Cancer Institute, Rotterdam, Netherlands.; Hoeben A; Maastricht University Medical Centre, Maastricht, Netherlands.; van Herpen CML; Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.; Westgeest HM; Amphia Ziekenhuis, Breda, Netherlands.; Wessels LFA; The Netherlands Cancer Institute, Amsterdam, NH, Netherlands.; Verheul HMW; Erasmus MC, Rotterdam, Netherlands.; Gelderblom H; Leiden University Medical Center, Leiden, Netherlands.; Voest EE; Netherlands Cancer Institute, Amsterdam, Netherlands.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Verkerk K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Haanen JBAG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Clinical Oncology, LUMC, Leiden, the Netherlands.; Head of Melanoma Clinic, CHUV, Lausanne, Switzerland.; van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.; Eskens FALM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.; Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Jalving M; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Gietema JA; Department of Medical Oncology, University of Medical Center Groningen, Groningen, the Netherlands.; Devriese LA; Department of Medical Oncology, Division Beeld & Oncologie, Utrecht University Medical Center, Utrecht, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Center, Location VUMC, Cancer Center Amsterdam, the Netherlands.; Barjesteh van Waalwijk van Doorn-Khosrovani S; CZ Health Insurance, Tilburg, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Smit EF; Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Academic Journal
Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Eisses B; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Zwager MC; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Bensch F; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; den Dekker MAM; Department of Radiology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, 3584 Utrecht, The Netherlands.; Kuip EJM; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud Medical Center, 6500 Nijmegen, The Netherlands.; Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands.; van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 Rotterdam, The Netherlands.; Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands.; de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; van der Vegt B; Department of Pathology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Menke-van der Houven van Oordt WC; Department of Medical Oncology, Amsterdam University Medical Center, Location VU University Medical Center, 1081 Amsterdam, The Netherlands.; Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, 9713 Groningen, The Netherlands.; Department of Medical Oncology, Dutch Cancer Institute, 1066 Amsterdam, The Netherlands.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE
Editorial & Opinion
Weijers JAM; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; de Bitter TJJ; Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands; Department of Human Genetics, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.; Verhaegh GW; Department of Urology, Radboud Institute for Molecular Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; van Boxtel W; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; Uijen MJM; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; van Engen-van Grunsven ACH; Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.; Driessen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; Schalken JA; Department of Urology, Radboud Institute for Molecular Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands.; Ligtenberg MJL; Department of Pathology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands; Department of Human Genetics, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, the Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud Institute for Medical Innovation, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, the Netherlands. Electronic address: Carla.vanHerpen@radboudumc.nl.
Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Academic Journal
van Wigcheren GF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands; Oncode Institute, The Netherlands.; Cuenca-Escalona J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Stelloo S; Oncode Institute, The Netherlands; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.; Brake J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Peeters E; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Horrevorts SK; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Frölich S; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.; Ramos-Tomillero I; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.; Wesseling-Rozendaal Y; Philips Research, Eindhoven, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.; van de Stolpe A; Philips Research, Eindhoven, The Netherlands.; Vermeulen M; Oncode Institute, The Netherlands; Faculty of Science, Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands.; de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands. Electronic address: jolanda.devries@radboudumc.nl.; Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands; Oncode Institute, The Netherlands.; Flórez-Grau G; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE
Academic Journal
de Heus E; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van de Camp K; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Driehuis E; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; van der Zwan JM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Merkx MAW; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; IQ Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.; Duijts SFA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (Integraal Kankercentrum Nederland, IKNL), Utrecht, The Netherlands.; Department of Medical Psychology, Amsterdam University Medical Centers, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
Publisher: Wiley Country of Publication: England NLM ID: 9214524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1611 (Electronic) Linking ISSN: 10579249 NLM ISO Abbreviation: Psychooncology Subsets: MEDLINE
Academic Journal
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Looze EJ; Division of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Thavaneswaran S; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van Berge Henegouwen JM; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; van der Wijngaart H; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Sebastian L; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lee CK; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Lin FP; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands.; Thomas DM; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Report
Bol KF; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Peeters E; Medical Imaging, Radboudumc, Nijmegen, Netherlands.; van Herpen CML; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Westdorp H; Medical Oncology, Radboudumc, Nijmegen, Netherlands.; Aarntzen EHJG; Medical Imaging, Radboudumc, Nijmegen, Netherlands.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Reerds STH; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands Sam.Reerds@radboudumc.nl.; Uijen MJM; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Van Engen-Van Grunsven ACH; Department of Pathology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Marres HAM; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Honings J; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE
Academic Journal
van Ravensteijn SG; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Nederkoorn MJL; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Wal TCP; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Braam PM; Department of Radiotherapy, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Flucke UE; Department of Pathology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Bonenkamp JJ; Department of Surgery, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Schreuder BHW; Department of Orthopedics, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; van Herpen CML; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; de Wilt JHW; Department of Surgery, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; Desar IME; Department of Medical Oncology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.; de Rooy JWJ; Department of Radiology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[AR] van Herpen CML
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어